Pharma Equity Group A/S (PEG.CO)

DKK 0.18

(-2.17%)

Annual Income Statements

(In DKK)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue - - - - - -
Cost of Revenue 480 Thousand - - - - -
Gross Profit -480 Thousand - - - - -
Operating Expenses 24.81 Million 2.77 Million -56 Thousand 12.13 Million 1.67 Million 1.67 Million
Selling, General and Administrative Expenses 15.73 Million 1.97 Million 1.44 Million 2.13 Million 1.67 Million 1.67 Million
Research and Development Expenses 9.08 Million 5497.00 - - - -
Other Expenses - 3.02 Million 4.9 Million -6.62 Million -7.39 Million 50 Thousand
Cost and Expenses 25.29 Million 2.77 Million -56 Thousand 12.13 Million 1.67 Million 1.67 Million
Operating Income -25.29 Million -4.27 Million -1.44 Million -2.13 Million -1.67 Million -1.67 Million
Interest Expense 1.56 Million 996 Thousand 665 Thousand 272 Thousand 30 Thousand 125 Thousand
Income Tax Expense -2.23 Million -7.3 Million -6.35 Million 15.47 Million 5.55 Million -5.33 Million
Earnings before Tax -26.84 Million 3.47 Million 5.39 Million -32.87 Million -14.41 Million -7.71 Million
Net Income -24.6 Million 3.47 Million 5.39 Million -32.87 Million -14.41 Million -7.71 Million
Earnings Per Share Basic -0.02 0.09 0.10 -1.03 -0.07 -0.32
Earnings Per Share Diluted -0.02 0.08 0.10 -1.03 -0.07 -0.32
Weighted Average Shares Outstanding 1.08 Billion 37.29 Million 55.57 Million 31.81 Million 203.79 Million 23.81 Million
Weighted Average Shares Outstanding (Diluted) 1.08 Billion 44.36 Million 55.57 Million 31.81 Million 203.79 Million 23.81 Million
Gross Margin - - - - - -
EBIT Margin - - - - - -
Profit Margin - - - - - -
EBITDA -24.79 Million 4.47 Million 6.05 Million -32.6 Million -14.38 Million -7.58 Million
Earnings Before Tax Margin - - - - - -

Income Statement Charts